Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CMS Energy heads into its October 27 earnings print with short sellers meaningfully more aggressive than they were a month ago, even as the broader lending market remains deeply relaxed.
Short interest has climbed roughly 22% over the past month, reaching 5.9% of the free float with 18.1 million shares short. The weekly pace has accelerated: up nearly 10% in the past seven days alone, the fastest build in the 30-day window. That level is not extreme for a regulated utility, but the direction of travel is notable. The borrow market tells a different story. Availability remains extraordinarily loose at 2,328%, meaning shares to borrow far outnumber those already borrowed. Cost to borrow is negligible at 0.44%, easing roughly 9% over the past month. With this much room in the lending pool, new shorts can establish positions cheaply and easily, which may partly explain why the build has been so orderly. Options positioning reinforces the picture: the put/call ratio is 0.09, slightly below its 20-day average of 0.10, and nowhere near stressed. The ORTEX short score has ticked up modestly to 43.8 from 41.6 at the end of September, still comfortably in mid-range, below the 50th percentile rank.
The Street is broadly constructive but has spent recent months steadily trimming targets. Truist Securities maintained its Buy but cut its target from $81 to $77 on October 14. BMO Capital did likewise, shaving its Outperform target from $77 to $73 on October 6. Morgan Stanley's Equal-Weight sits at $77, down from $79 in August. The mean analyst target is $76.92, implying roughly 16% upside to the current $66.30 close, a gap wide enough to stay interesting but consistent with a sector that has de-rated through the year. The bull case rests on visible above-average earnings growth and rate relief lifting the regulated utility; the PE is 16.2x and EV/EBITDA 10.5x, both relatively modest for a multi-utility. The bear case centres on tighter monetary policy constraining financial flexibility, slower rate-base growth at Consumers Energy, and potential unwinding of IRA benefits at the NorthStar Clean Energy segment. Forward earnings-per-share growth scores in the 95th percentile, the standout factor in an otherwise middling scorecard: dividend score ranks 87th percentile, while EPS momentum at both 30 and 90 days sits in the low 40s and the short-score rank is 28th percentile.
One index-related dynamic is worth flagging ahead of December. ORTEX forecasts a 52% probability that CMS joins the CRSP US Small index at the December 2026 Quarterly Review, with the rank date on December 4 and the trade date December 22. If it qualifies, trackers would need to buy roughly $330 million worth of stock, equivalent to 1.3 days of normal trading volume. To reach the entry line, the stock needs to close above $67.59, a gain of about 1.9% from here. At the same review, ORTEX puts a 52% chance on share-count reductions in both the CRSP US Large ($61 million of selling) and CRSP US Mid ($201 million of selling) indices. The combined mechanic, potential small-cap buying offset by mid- and large-cap selling, is not a clean tailwind, and the probabilities are coin-flip territory rather than certainties.
The most recent open-market insider purchase was the CFO's $14,491 buy in late July, a small and modest signal that adds little to the positioning picture. Wellington Management is the name worth watching among institutions: it added 5.5 million shares in its most recent filing, the largest single increase among top-ten holders.
The past two earnings events produced a split pattern: a 0.1% gain on the day followed by a 3.4% five-day decline in July, and a 3.2% one-day drop the time before. Neither print delivered sustained upside in the five-day window. With the October 27 release thirteen days away, the pace of the short rebuild and whether the stock can hold above $67.59 are the two numbers worth tracking.
See the live data behind this article on ORTEX.
Open CMS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
